NCT00813176

Brief Summary

The purpose of this study is to determine whether the double-lumen endotracheal tube or the standard single-lumen tracheal tube, with an Arndt® blocker, is superior in providing one lung ventilation during thoracic surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Mar 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2007

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

December 18, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 22, 2008

Completed
9.5 years until next milestone

Results Posted

Study results publicly available

June 4, 2018

Completed
Last Updated

June 4, 2018

Status Verified

May 1, 2018

Enrollment Period

1.8 years

First QC Date

December 18, 2008

Results QC Date

July 6, 2017

Last Update Submit

May 1, 2018

Conditions

Keywords

ObesityOne-Lung VentilationAnesthesiaThoracicOne-lung ventilation in the morbidly obese patient

Outcome Measures

Primary Outcomes (2)

  • Time Taken for Endotracheal Tube Placement Procedure.

    For each group, the time in minutes required for the anesthesiologist to successfully place the endotracheal tube. Intubation time was recorded as the time from when the tracheal tube passed the vocal cords until the anesthetist concluded that the DLT (Arm 1) or the single-lumen tube with the Arndt blocker (Arm 2) was correctly placed and optimal position was confirmed with the fiberoptic bronchoscope.

    This measurement occurred after the patient was in the operating room and the randomization group was determined. This measurement began and ended during the intubation procedure.

  • Number of Participants in Which the Tube Was Successfully Positioned at First Attempt

    Number of participants in each group in which the tube was successfully positioned at first attempt

    This data measure was occurred during surgery.

Secondary Outcomes (4)

  • Effectiveness of Lung Collapse

    This measure occured during surgery just after intubation.

  • Time Required to Collapse the Lung

    This measurement occurred during surgery.

  • Number of Participants With Successful Reinflation

    This occurred during surgery.

  • Mean Intraoperative Oxygenation During One-lung Ventilation

    This measure occured during surgery.

Study Arms (2)

Double Lumen Endotracheal Tube

ACTIVE COMPARATOR

We used a device called a double lumen tube ( DLT Broncho-Cath®). It is a bifurcated endotracheal tube designed to independently collapse the operated lung.

Device: Double Lumen Endotracheal Tube

Arndt Bronchial Blocker

ACTIVE COMPARATOR

We used a device called a bronchial blocker (9 Fr Arndt® blocker) along with a standard single-lumen tracheal tube (8.0-9.0 mm ID). The Arndt bronchial blocker is a single device, with a distal balloon that is passed thru the single lumen endotracheal once the patient is intubated. The Arndt bronchial blocker is designed to collapse the operated lung.

Device: Arndt Bronchial Blocker

Interventions

Double Lumen Endotracheal Tube
Arndt Bronchial Blocker

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject undergoing thoracic or esophageal surgery requiring one-lung ventilation.
  • Subject is \>18 years of age.
  • Subject's BMI \> 35.

You may not qualify if:

  • Subject \< 18 years of age.
  • Subject's BMI \< 35.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Iowa

Iowa City, Iowa, 52241, United States

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr Javier H Campos
Organization
University of Iowa

Study Officials

  • Javier H Campos, MD

    Iowa Health Care

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: prospective randomized study
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor in Anesthesia

Study Record Dates

First Submitted

December 18, 2008

First Posted

December 22, 2008

Study Start

March 1, 2007

Primary Completion

December 1, 2008

Study Completion

December 1, 2008

Last Updated

June 4, 2018

Results First Posted

June 4, 2018

Record last verified: 2018-05

Locations